The Canadian PressJune 13, 2013 04:32
BEIJING, China - Drug manufacturer GlaxoSmithKline said Thursday it has investigated an accusation that its salespeople in China bribed doctors and found no evidence of wrongdoing.
The company said it conducted a four-month investigation after receiving complaints from an anonymous source. It said it found "no evidence of corruption or bribery in our China business."
GlaxoSmithKline PLC is headquartered in Britain but has a presence in the United States, which could make it liable to penalties under U.S. anti-bribery laws.
Follow us: